Inven2 is the next-generation innovation company, established to maintain and develop Norwegian innovations. We build bridges between excellent research and the next generation technology based industry.
Inven2 is the largest contributor in Norway within the field of commercialization of research, owned by the University of Oslo and Oslo University Hospital, Norway's largest and leading university and hospital representing pioneering research.
Inven2's Board of Directors.
We are responsible for:
- Commercializing of innovations from our owners
- Administration and financial follow up of clinical trials
Inven2s ambition is to build new businesses based on cutting-edge technology from our owners.
"Knowledge-based business development based on cutting-edge technology"